Skip to main content

Table 3 Antimicrobial activities for the ethanolic extracts of different wild mushroom strains by using a well diffusion method

From: Molecular identification and antimicrobial activities of some wild Egyptian mushrooms: Bjerkandera adusta as a promising source of bioactive antimicrobial phenolic compounds

Pathogenic microbial strains

The diameter of inhibition zone (mm)*

Gentamycin (10 ÎĽg/well)

Bjerkandera adusta (MN602043)

Cyclocybe cylindracea (MN646676)

Agrocybe aegerita (MN635615)

Chlorophyllum molybdites (MN638772)

Lentinus squarrosulus (MN602044)

Gram-positive bacteria

Streptococcus pneumoniae

10.0 ± 0.00

17.0 ± 0.20

20.0 ± 0.29

-

12.0 ± 0.33

15.0 ± 0.10

Staphylococcus aureus ATCC25923

8.0 ± 0.00

15.0 ± 0.10

13.0 ± 0.12

-

-

-

Micrococcus luteus

9.0 ± 0.00

22.0 ± 0.10

14.0 ± 0.22

-

-

-

Gram-negative bacteria

Escherichia coli ATCC25922

2.0 ± 0.00

12.0 ± 0.30

17.0 ± 0.20

2.0 ± 0.00

-

-

Pseudomonas aeruginosa ATCC 7853

10.0 ± 0.00

10.0 ± 0.52

17.0 ± 0.00

2.0 ± 0.00

10.0 ± 0.41

20.0 ± 0.22

Proteus mirabilis

-

-

-

-

-

-

Yeast

Candida albicans ATCC1031

-

12.0 ± 011

14.0 ± 0.00

-

-

-

  1. Values for the zone of growth inhibition (measured as the diameter of the clear zone around the well) are means ± SD of three independent replicas. The diameter of the well (5 mm) is included
  2. “-” indicates no inhibition